Tag: Antipsychotics
New Research on Patient-Centered Deprescribing for Antipsychotics
Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.
Study Shows Success With Reduced Antipsychotic Use
People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.
Study Reduces Over-prescription of Antipsychotics in Older Adults
New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.
Challenges for the Next Phase of Integrated Medicaid Care in OR
From The Lund Report: "Access to the current disease-centered system of mental health care will almost certainly mean worse outcomes for many people than if...
His Lovely Wife in the Psych Ward (Podcast)
From Psychiatric Times: "After the first episode, when Giulia was healthy and balanced and stable in between, she was really mad at me, and I...
Patients’ Drug Options Under Medicaid Influenced by Drugmakers
From NPR: "A Center for Public Integrity and NPR investigation found drug companies have infiltrated nearly every part of the process that determines how their drugs will be covered...
New Research Suggests Brain Abnormalities in âSchizophreniaâ May Result From Antipsychotics
Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.
FDA Repays Industry by Rushing Risky Drugs to Market
From ProPublica:Â "The FDA is increasingly green-lighting expensive drugs despite dangerous or little-known side effects and inconclusive evidence that they curb or cure disease. Once...
FDA Defends Decision to Approve Digital Aripiprazole
Members of the U.S. Food and Drug Administrationâs Psychiatry Products division go on the defensive in a new article, responding to concerns about the agencyâs approval of digital aripiprazole.
“The Angry Consumer”: Embracing Difficult Conversations
Judgments of the so-called âangry consumerâ deeply reinforce divisions within mental health policy and services. The only way we can engage in meaningful co-production is not to gloss over histories of collective exclusion and disempowerment and all the pain and anger that goes with it, but rather to validate and work through difficult emotions.
Children on Antipsychotics at Risk for Weight Gain and Diabetes
From U.S. News: "Children and adolescents treated with antipsychotic medications experience weight gain and develop an increased risk of diabetes, according to a new...
Royal College of Psychiatrists Accused of Misleading Claims
From The Herald: A group of mental health experts and patients have submitted a formal letter of complaint accusing the Royal College of Psychiatrists of...
For-Profit Medicine Incentivizes Overmedicating Our Elderly
From NBC: According to human rights investigators, anti-psychotic drugs are often administered to nursing home residents to address behavioral issues. Our nation's lack of funding...
Care Homes Over-Prescribing Drugs for Residents with Dementia
From The Guardian: According to a new Human Rights Watch report, U.S. nursing homes are inappropriately prescribing antipsychotics to an estimated 179,000 residents with dementia each...
Psychiatry is a Disaster Area in Healthcare That Needs Attention
In this piece for The BMJ, Dr. Peter Gøtzsche points out several of the major problems with the drug-based paradigm of psychiatric care as well as...
Antipsychotics, Restraints, and Seclusion Raising Concerns
From ABC Australia: Australia's high rate of antipsychotic prescriptions, as well as the frequent usage of restraints and seclusion, has raised concerns among Australian mental health advocates, researchers,...
Reexamining Schizophrenia as a Brain Disease
Schizophrenia has occupied, and continues to occupy, a position of great import in psychiatry, and it is frequently used to assert the supposed biological nature of the field. What evidence is there to suggest that what we call schizophrenia is a disease of the brain? Surprisingly, very little.
Patients on Antipsychotics at High Risk for Cardiovascular Issues, Study Finds
Antipsychotics present a known risk for major side effects. A new study suggests that certain antipsychotics may present a greater risk for cardiovascular disease than others.
Tranquilizing Humanity into Oblivion: A Warning from Nathan S. Kline
Widely heralded as the father of American psychopharmacology, Kline insisted that his discoveries were adjunctive to psychotherapy, not replacements. The psychopharmacology of Kline's era recognized that medications are a blunt instrument.
Mortality of People Using Mental Health Services and Medications
153,451 deaths were registered in Australia in the period 10 August 2011 to 27 September 2012. 75,858 of these deaths were registered for persons who had accessed mental health-related treatments. These deaths accounted for 49.4% of all deaths in this period.
Olga Runciman: Moving Beyond Psychiatry
This week on the Mad in America podcast we interview Olga Runciman. Olga is an international trainer and speaker, writer, campaigner, and artist. In this interview, we discuss Olgaâs professional and personal experiences of the psychiatric system and how she now helps and supports healing and recovery in others.
Inappropriate Use of Antipsychotics on Adults with Intellectual and Developmental Disabilities
One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.
Study Identifies Cause of Weight Gain From Antipsychotic Drugs
From UPI: A team of researchers from the University of Texas Southwestern Medical Center found that the serotonin 2c receptor is responsible for weight gain...
Increased Risk of Movement Disorders From Antipsychotics in Persons with Intellectual...
Large cohort study demonstrates that those with an intellectual disability are at an increased risk for movement disorder side effects of antipsychotics.
Patients With Schizophrenia Show Better Work Functioning Off Antipsychotics
20-year follow-up study finds that after four years, patients not prescribed antipsychotics have significantly better work functioning.